The US Food and Drug Administration (FDA) has planned a sweeping modernisation of regulatory science used to evaluate products in an attempt to boost pharmaceutical innovation.

The administration’s new strategic plan for regulatory science hopes to enhance product safety through modernised toxicology, facilitate the development of medical countermeasures to protect the public from potential security threats and implement a new prevention-based food safety system.

Advances in innovative science and new technologies have forced the agency to adapt and keep pace with scientific advances in order to continue to fulfil its purpose.

The plan also emphasised a need for the agency to improve how it communicates health information to consumers.

The FDA hopes to implement the plan through management of FDA-run scientific programmes and by collaborating with partners within the pharmaceutical industry, as well as academia and government officials.